Lv1
20 积分 2024-06-18 加入
Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohort
2天前
已完结
Immunotherapeutic strategies for the treatment of ovarian cancer: current status and future direction
8天前
已完结
Neoadjuvant Chemotherapy with Dual Immune Checkpoint Inhibitors for Advanced-Stage Ovarian Cancer: Final Analysis of TRU-D Phase II Nonrandomized Clinical Trial
8天前
已完结
HER2 Protein Overexpression and Gene Amplification in Tubo-Ovarian High-grade Serous Carcinomas
1个月前
已完结
Non small cell lung cancer with SMARCA4 deficiency harboring rare EGFR mutations exhibited significant tumor response when treated with afatinib: a case report
1个月前
已完结
Real-World Genomic Profile of EGFR Second-Site Mutations and Other Osimertinib Resistance Mechanisms and Clinical Landscape of NSCLC Post-Osimertinib
1个月前
已完结
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting C797S Mutation
1个月前
已完结
Overcoming C797S mutation: The challenges and prospects of the fourth-generation EGFR-TKIs
1个月前
已完结
Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations
1个月前
已完结
A lung adenocarcinoma with rare epidermal growth factor receptor exon 20 V774M mutation was sensitive to osimertinib: A case report and molecular structural analysis
1个月前
已完结
皖公网安备34019202002308
